Novel capsules for potential theranostics of obscure gastrointestinal bleedings

详细信息    查看全文

• 作者：Bayram Ç ; olak^a ; ^{colakbayram@selcuk.edu.tr" class="auth_mail" title="E-mail the corresponding author} ; Hü ; seyin Şakalak^b ; ^c ; Halit Ç ; avuşoğlu^b ; ^c ; Mustafa Selman Yavuz^b ; ^c ; ^{selmanyavuz@selcuk.edu.tr" class="auth_mail" title="E-mail the corresponding author}
• 刊名：Medical Hypotheses
• 出版年：2016
• 出版时间：September 2016
• 年：2016
• 卷：94
• 期：Complete
• 页码：99-102
• 全文大小：516 K

文摘

Obscure gastrointestinal (GI) bleeding is identified as persistent or repeated bleeding from the gastrointestinal tract which could not be defined by conventional gastrointestinal endoscopy and radiological examinations. These GI bleedings are assessed through invasive diagnostic and treatment methods including enteroscopy, angiography and endoscopy. In addition, video capsule endoscopy (VCE) is a non-invasive method used to determine the location of the bleeding, however, this does not provide any treatment. Despite of these successful but invasive methods, an effective non-invasive treatment is desperately needed. Herein, we prepare non-invasive theranostic capsules to cure obscure GI bleeding. An effective theranostic capsule containing endothelin as the targeting agent, thrombin-fibrinogen or fibrin as the treating agent, and fluorescein dye as the diagnostic tool is suggested. These theranostic capsules can be administered orally in a simple and non-invasive manner without a risk of complication. By using these novel capsules, one can diagnose obscure GI bleeding with having a possibility of curing.